These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29602443)

  • 1. [Resistance to vitamin K antagonist revealing interaction with soy lecithin].
    Ksouda K; Affes H; Ghorbel A; Chtourou L; Guidara R; Tahri N; Hammami S; Zeghal K
    Ann Cardiol Angeiol (Paris); 2018 Apr; 67(2):98-100. PubMed ID: 29602443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of soy milk on warfarin efficacy.
    Cambria-Kiely JA
    Ann Pharmacother; 2002 Dec; 36(12):1893-6. PubMed ID: 12452752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Br J Haematol; 2010 May; 149(4):598-605. PubMed ID: 20151978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.
    Kooistra HA; Gebel M; Sahin K; Lensing AW; Meijer K
    Thromb Haemost; 2015 Nov; 114(6):1136-43. PubMed ID: 26224199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probable interaction between an oral vitamin K antagonist and turmeric (Curcuma longa).
    Daveluy A; Géniaux H; Thibaud L; Mallaret M; Miremont-Salamé G; Haramburu F
    Therapie; 2014; 69(6):519-20. PubMed ID: 25230280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists.
    Pottegård A; dePont Christensen R; Wang SV; Gagne JJ; Larsen TB; Hallas J
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1160-7. PubMed ID: 25250949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-of-care testing and INR within-subject variation in patients receiving a constant dose of vitamin K antagonist.
    van den Besselaar AM; Biedermann JS; Kruip MJ
    Thromb Haemost; 2015 Nov; 114(6):1260-7. PubMed ID: 26202616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone.
    Costedoat-Chalumeau N; Amoura Z; Aymard G; Sevin O; Wechsler B; Cacoub P; Du LT; Diquet B; Ankri A; Piette JC
    Ann Intern Med; 2000 Apr; 132(8):631-5. PubMed ID: 10766681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.
    Ageno W; Crowther M; Steidl L; Ultori C; Mera V; Dentali F; Squizzato A; Marchesi C; Venco A
    Thromb Haemost; 2002 Jul; 88(1):48-51. PubMed ID: 12152676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary vitamin K variability affects International Normalized Ratio (INR) coagulation indices.
    Couris R; Tataronis G; McCloskey W; Oertel L; Dallal G; Dwyer J; Blumberg JB
    Int J Vitam Nutr Res; 2006 Mar; 76(2):65-74. PubMed ID: 16941417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Body Weight on Dose of Vitamin K Antagonists.
    Self TH; Wallace JL; Sakaan S; Sands CW
    South Med J; 2015 Oct; 108(10):637-43. PubMed ID: 26437201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].
    Valdelièvre E; Quéré I; Caré B; Laroche JP; Schved JF
    J Med Vasc; 2018 May; 43(3):155-162. PubMed ID: 29754725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation.
    Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Dourliou V; Sofogianni A; Savopoulos C; Hatzitolios AI
    J Thromb Thrombolysis; 2016 Feb; 41(2):336-42. PubMed ID: 26253707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
    De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
    Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina.
    Tajer C; Ceresetto J; Bottaro FJ; Martí A; Casey M;
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):445-453. PubMed ID: 26739542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches to optimal dosing of vitamin K antagonists.
    Witt DM
    Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy.
    Dillinger JG; Si Moussi T; Berge N; Bal Dit Sollier C; Henry P; Drouet L
    Thromb Res; 2016 Apr; 140():66-72. PubMed ID: 26901852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High intra- and inter-individual variability of plasma vitamin K concentrations in patients with atrial fibrillation under warfarin therapy.
    Kim YE; Woo HI; On YK; Kim JS; Lee SY
    Eur J Clin Nutr; 2015 Jun; 69(6):703-6. PubMed ID: 25828628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory Monitoring of Oral Vitamin K Anticoagulation.
    Moffat KA; Lewis CW
    Semin Thromb Hemost; 2017 Apr; 43(3):245-252. PubMed ID: 27677177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.